Related Experiment Video
Updated: Mar 14, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Cardiovascular Disease and HIV: Pathophysiology, Treatment Considerations, and Nursing Implications
Justin M Cournoyer1, Aven P Garms1, Kimberly N Thiessen1
1Justin M. Cournoyer is a clinical nurse I in the pediatric cardiac intensive care unit, Duke University Hospital, Durham, North Carolina.Aven P. Garms is a clinical nurse I in the intensive care nursery, Duke University Hospital.Kimberly N. Thiessen is a staff nurse in the pediatric emergency department, WakeMed Health and Hospitals, Raleigh, North Carolina.Margaret T. Bowers is an associate professor and the faculty coordinator of the adult/geriatric nurse practitioner program and the lead faculty member for the adult/geriatric nurse practitioner-cardiovascular specialty at Duke University School of Nursing, Durham, North Carolina.Melissa D. Johnson is an associate professor in medicine, Duke University Medical Center, Durham, North Carolina, and Campbell University, Buies Creek, North Carolina.Michael V. Relf is an associate professor and the associate dean for global and community affairs, Duke University School of Nursing.
Insights
Cardiovascular disease is the leading cause of death for people with HIV (PLWH). Aging, HIV, and treatments increase risks, necessitating specialized nursing care for better patient outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Nursing
Background:
- HIV infection has transitioned from an acute, terminal illness to a chronic condition.
- Cardiovascular disease (CVD) is now the primary cause of mortality among people living with HIV (PLWH).
- Aging populations of PLWH face compounded risks from traditional atherosclerosis factors, HIV's effects, and antiretroviral therapies.
Observation:
- PLWH exhibit a significantly elevated risk for atherosclerosis.
- Cardiomyopathy is a prevalent concern in the PLWH population.
- Critical care nurses require comprehensive knowledge of CVD risk factors, pathophysiology, and treatments in PLWH.
Findings:
- Traditional atherosclerosis risk factors are exacerbated by HIV infection and its treatments.
- HIV-positive individuals are at high risk for developing cardiomyopathy.
- Effective management requires recognizing complex risk profiles and treatment modalities.
Implications:
- Critical care nurses play a vital role in managing CVD in PLWH.
- Multidisciplinary collaboration is essential for optimal patient care.
- Understanding unique risk factors and treatment nuances improves outcomes for PLWH with CVD.
Abstract:
HIV infection has progressed from an acute, terminal disease to a chronic illness with cardiovascular disease as the leading cause of death among persons living with HIV. As persons living with HIV infection continue to become older, traditional risk factors for atherosclerosis compounded by the pathophysiological effects of HIV infection and antiretroviral therapy markedly increase the risk for cardiovascular disease. Further, persons living with HIV are also at high risk for cardiomyopathy. Critical care nurses must recognize the risk factors for cardiovascular disease and the pathophysiology and complex treatment options in order to manage care of these patients and facilitate multidisciplinary collaboration. Two case studies are used to highlight the treatment options and nursing considerations associated with cardiovascular disease among persons living with HIV.
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
Cardiomyopathy VI: Nursing Management
Atherosclerosis IV: Nursing Management
Sexually Transmitted Infections
Myocarditis IV: Nursing Management
Pericarditis IV: Nursing Management

